Arunjyothi Bio Ventures Complete Financial Statements
In FY2010, Arunjyothi Bio Ventures (ABVL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00. Full financial statements from FY2010 to FY2025 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see ABVL share price.
12 Years of Data
2025 - 2010
Complete Financial Data Export
Profitability Ratios
Operating Margin
38.00%
2010 data
Balance Sheet Ratios
Current Ratio
0.68
2010 data
Equity Ratio
53.33%
2010 data
ABVL Revenue, Net Profit & EBITDA — Year-on-Year Growth
ABVL YoY (Dec 2010 vs Sept 2010).
Assets Growth
+11.1%
Year-over-Year
Equity Growth
+1500.0%
Year-over-Year
Operating Cash Flow Growth
-66.7%
Year-over-Year
Investing Cash Flow Growth
+73.9%
Year-over-Year
Financing Cash Flow Growth
-68.8%
Year-over-Year
ABVL Income Statement — Revenue, EBITDA & Net Profit
Arunjyothi Bio Ventures revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (2010). Explore ABVL fundamental worth to estimate fundamental worth using multiple valuation models.
Periods
₹ Crores
| Particulars | Sept 2010 | Dec 2010 |
|---|---|---|
| Revenue | 0 | 0 |
| Expenses | 0 | 0 |
| EBITDA | 0 | 0 |
| Operating Profit Margin % | 38.00% | 31.00% |
| Depreciation | 0 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 0 | 0 |
| Tax | 0 | 0 |
| Net Profit | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | 0.19 |
ABVL Balance Sheet — Assets, Liabilities & Shareholders' Equity
ABVL total assets ₹60 Cr, total equity ₹32 Cr, total liabilities ₹ Cr (2025).
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 60 | 54 | 36 | 2 | 5 | 6 | 6 | 10 | 20 | 2 | 2 |
| Current Assets | 15 | 11 | 6 | 1 | 3 | 4 | 4 | 9 | 18 | 0 | 0 |
| Fixed Assets | 43 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 16 | 14 | 17 | 2 | 5 | 6 | 6 | 10 | 20 | 2 | 2 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 22 | 47 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 32 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Share Capital | 19 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves & Surplus | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ABVL Cash Flow Statement — Operating, Investing & Financing
Arunjyothi Bio Ventures operating cash flow ₹2 Cr, investing ₹-6 Cr, financing ₹5 Cr, net cash flow ₹1 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 2 | 6 | -13 | -1 | 0 | 1 | -3 | 3 | 0 | 0 | 0 |
| Investing Activities | -6 | -23 | -19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 5 | 16 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 1 | 0 | 0 | -1 | 0 | 1 | -3 | 3 | 0 | 0 | 0 |